Ionis Pharmaceuticals IONS Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's deferred taxes?
- Ionis Pharmaceuticals (IONS) reported deferred taxes of $218K in Q1 2026.
- How has Ionis Pharmaceuticals's deferred taxes changed year-over-year?
- Ionis Pharmaceuticals's deferred taxes increased by 87.9% year-over-year, from $116K to $218K.
- What does deferred taxes mean?
- Non-cash tax adjustments representing future tax liabilities or assets due to timing differences.
- How do you interpret deferred taxes?
- A large deferred tax asset suggests future tax savings, while a large deferred tax liability suggests future tax payments.
- How does deferred taxes compare across companies?
- Standard line item on the cash flow statement for all companies with significant temporary tax differences.